Category: Market/Novel Tech

Month: 08 Aug 2012

Issue: not yet available

Canadian ophthalmic company QLT Inc. plans to return $100M cash to shareholders

QLT Inc., (Nasdaq: QLTI; TSX: QLT), a public biotech company focused on the commercialization of innovative ophthalmic products has announced significant corporate and structural re-organisation, including the return of $100M in cash to its shareholders. Based in Vancouver, Canada the company has undergone significant re-structuring since an activist shareholder, NB Public Equity Komplementar ApS, gained control of the company.

Back to previous

Related News

Gearoid Tuohy

editor

by Dr. Gearóid Tuohy   Dear EURETINA Members,   A very warm welcome to the December 4th, 2017 edition of EURETINA’s web-based digital magazine, “EURETINA Brief”. EURETINA are delighted to continue our delivery of up-to-date summary briefs on a range of topics of interest to retinal clinicians, specialists and researchers across Europe. This resource is […]